Evidence map›Paper›PMID 29368244›Full record

ArticleLa Radiologia medica2018

Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT.

Valerio Nardone, Paolo Tini, Christophe Nioche, Maria Antonietta Mazzei, Tommaso Carfagno, Giuseppe Battaglia, Pierpaolo Pastina, Roberta Grassi, Lucio Sebaste, Luigi Pirtoli

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in La Radiologia medica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Evaluation of CT-based radiomics signature and nomogram as prognostic markers in patients with laryngeal squamous cell carcinoma.Cancer imaging : the official publication of the International Cancer Imaging Society · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Valerio NardoneIstituto Toscano Tumori, Florence, Italy. v.nardone@hotmail.it.ORCID http://orcid.org/0000-0002-7347-0965
Paolo TiniIstituto Toscano Tumori, Florence, Italy.
Christophe NiocheIMIV, CEA, Inserm, CNRS, Univ. Paris-Sud, Université Paris Saclay, CEA-SHFJ, 91 400, Orsay, France.
Maria Antonietta MazzeiIstituto Toscano Tumori, Florence, Italy.
Tommaso CarfagnoIstituto Toscano Tumori, Florence, Italy.
Giuseppe BattagliaIstituto Toscano Tumori, Florence, Italy.
Pierpaolo PastinaIstituto Toscano Tumori, Florence, Italy.
Roberta GrassiUnit of Radiation Oncology, University Hospital of Florence, Florence, Italy.
Lucio SebasteIstituto Toscano Tumori, Florence, Italy.
Luigi PirtoliIstituto Toscano Tumori, Florence, Italy.
University of Siena · ITUniversité Paris-Sud · FRUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeImage texture analysis (TA) is a heterogeneity quantifying approach that cannot be appreciated by the naked eye, and early evidence suggests that TA has great potential in the field of oncology. The aim of this study is to evaluate parotid gland texture analysis (TA) combined with formal dosimetry as a factor for predicting severe late xerostomia in patients undergoing radiation therapy for head and neck cancers.

methodsWe performed a retrospective analysis of patients treated at our Radiation Oncology Unit between January 2010 and December 2015, and selected the patients whose normal dose constraints for the parotid gland (mean dose < 26 Gy for the bilateral gland) could not be satisfied due to the presence of positive nodes close to the parotid glands. The parotid gland that showed the higher V30 was contoured on CT simulation and analysed with LifeX Software©. TA parameters included features of grey-level co-occurrence matrix (GLCM), neighbourhood grey-level dependence matrix (NGLDM), grey-level run length matrix (GLRLM), grey-level zone length matrix (GLZLM), sphericity, and indices from the grey-level histogram. We performed a univariate and multivariate analysis between all the texture parameters, the volume of the gland, the normal dose parameters (V30 and Mean Dose), and the development of severe chronic xerostomia.

resultsSeventy-eight patients were included and 25 (31%) developed chronic xerostomia. The TA parameters correlated with severe chronic xerostomia included V30 (OR 5.63), Dmean (OR 5.71), Kurtosis (OR 0.78), GLCM Correlation (OR 1.34), and RLNU (OR 2.12). The multivariate logistic regression showed a significant correlation between V30 (0.001), GLCM correlation (p: 0.026), RLNU (p: 0.011), and chronic xerostomia (p < 0.001, R2:0.664).

conclusionsXerostomia represents an important cause of morbidity for head and neck cancer survivors after radiation therapy, and in certain cases normal dose constraints cannot be satisfied. Our results seem promising as texture analysis could enhance the normal dose constraints for the prediction of xerostomia.

Indexed as

Radiographic Image Interpretation, Computer-AssistedTomography, X-Ray ComputedAdultAgedAged, 80 and overFemaleHead and Neck NeoplasmsHumansMaleMiddle AgedParotid GlandPredictive Value of TestsRadiotherapy, Intensity-ModulatedRetrospective StudiesSoftwareXerostomiaHead and neck cancerRadiation therapyTexture analysisXerostomia

Identifiers

PMID29368244
OpenAlexW2791826152

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.